Back to Agenda
Session 11: Reporting Adverse Events (AEs) During Clinical Trials
Session Chair(s)
Elliott Berger, PHD, MS
President
ETB Regulatory Consulting, United States
- Definitions of Terms
- IND Safety Reports
- IND Annual Reports - Safety Information
- Discontinuation of Studies for Safety Reasons
Have an account?